Article info
Professional matters
Review
Implications of recurrent SARS-CoV-2 outbreaks for IBD management
- Correspondence to Dr Jonathan P Segal, Gastroenterology and Hepatology, St Mary's Hospital, London W2 1NY, UK; jonathansegal1{at}nhs.net
Citation
Implications of recurrent SARS-CoV-2 outbreaks for IBD management
Publication history
- Received May 4, 2020
- Revised June 9, 2020
- Accepted June 14, 2020
- First published June 24, 2020.
Online issue publication
January 09, 2022
Article Versions
- Previous version (7 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage